MedCap AB (publ) reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was SEK 364.5 million compared to SEK 241.5 million a year ago. Revenue was SEK 368.1 million compared to SEK 264 million a year ago. Net income was SEK 38.3 million compared to SEK 36.6 million a year ago. Basic earnings per share from continuing operations was SEK 2.6 compared to SEK 2.5 a year ago. Diluted earnings per share from continuing operations was SEK 2.6 compared to SEK 2.5 a year ago.
For the nine months, sales was SEK 1,130.8 million compared to SEK 788.5 million a year ago. Revenue was SEK 1,142.2 million compared to SEK 816 million a year ago. Net income was SEK 110 million compared to SEK 77.3 million a year ago. Basic earnings per share from continuing operations was SEK 7.4 compared to SEK 5.2 a year ago. Diluted earnings per share from continuing operations was SEK 7.4 compared to SEK 5.2 a year ago.